A detailed history of Gamma Investing LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Gamma Investing LLC holds 187 shares of BPMC stock, worth $17,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
187
Previous 186 0.54%
Holding current value
$17,606
Previous $20 Million 13.71%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$84.1 - $120.5 $84 - $120
1 Added 0.54%
187 $17.3 Million
Q2 2024

Jul 02, 2024

BUY
$85.18 - $108.78 $5,281 - $6,744
62 Added 50.0%
186 $20 Million
Q1 2024

Apr 05, 2024

BUY
$73.17 - $99.79 $1,975 - $2,694
27 Added 27.84%
124 $11.8 Million
Q4 2023

Feb 01, 2024

BUY
$43.96 - $92.84 $4,264 - $9,005
97 New
97 $7.71 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.62B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.